Atlas Venture Fund X, L.P.

4 filings 3 distinct issuers Active 2020-07-07 → 2026-05-28

Track Record

Total filings

1 SCHEDULE 13D/A · 3 SC

Distinct issuers

75% issuer diversity

Median stake

3.6%

864,261 avg shares

AI briefs cached

0/4

intent-classified filings

Filed	Form	Issuer	Stake	Shares
2026-05-28	SCHEDULE 13D/A	Q32 Bio Inc.QTTB	3.60%	864,261	view →
2022-12-06	SC	Replimune Group, Inc.REPL	—	—	view →
2021-02-16	SC	Spero Therapeutics, Inc.SPRO	—	—	view →
2020-07-07	SC	Replimune Group, Inc.REPL	—	—	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.